AIM ImmunoTech Inc. (AIM)
USD 0.2
(-6.89%)
USD 0.2
(-6.89%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -31.67 Million USD | -80.52% |
| 2022 | -19.86 Million USD | -25.66% |
| 2021 | -18.25 Million USD | -8.43% |
| 2020 | -13.02 Million USD | -20.41% |
| 2019 | -8.14 Million USD | -3.9% |
| 2018 | -8.4 Million USD | -44.82% |
| 2017 | -7.11 Million USD | 42.54% |
| 2016 | -6.33 Million USD | 18.04% |
| 2015 | -14.25 Million USD | 12.7% |
| 2014 | -16.74 Million USD | -11.5% |
| 2013 | -15.51 Million USD | 14.13% |
| 2012 | -16.64 Million USD | 1.64% |
| 2011 | -8.34 Million USD | -11.38% |
| 2010 | -12.34 Million USD | -34.22% |
| 2009 | -12.45 Million USD | -1.55% |
| 2008 | -12.09 Million USD | 34.88% |
| 2007 | -17.3 Million USD | -4.84% |
| 2006 | -17.76 Million USD | -238.89% |
| 2005 | -6.78 Million USD | -135.71% |
| 2004 | 1.35 Million USD | 91.58% |
| 2003 | 2.06 Million USD | 210.95% |
| 2002 | -6.32 Million USD | 16.82% |
| 2001 | -8.27 Million USD | 2.32% |
| 2000 | -8.55 Million USD | 8.87% |
| 1999 | -12.46 Million USD | -38.81% |
| 1998 | -6.89 Million USD | -3.08% |
| 1997 | -6.2 Million USD | -30.0% |
| 1996 | -4.7 Million USD | -525.0% |
| 1995 | -700 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -5.67 Million USD | 59.22% |
| 2024 Q2 | -3.63 Million USD | 71.94% |
| 2023 Q4 | -13.93 Million USD | -78.25% |
| 2023 Q2 | -4.73 Million USD | -6.93% |
| 2023 Q3 | -7.81 Million USD | -65.07% |
| 2023 Q1 | -4.42 Million USD | -2.69% |
| 2023 FY | - USD | -80.44% |
| 2022 Q1 | -2.88 Million USD | 23.9% |
| 2022 FY | - USD | -25.66% |
| 2022 Q4 | -4.31 Million USD | 28.05% |
| 2022 Q3 | -5.99 Million USD | -37.61% |
| 2022 Q2 | -4.35 Million USD | -50.8% |
| 2021 Q3 | -3.68 Million USD | -15.0% |
| 2021 FY | - USD | -8.43% |
| 2021 Q4 | -3.79 Million USD | -3.1% |
| 2021 Q1 | -3.26 Million USD | 8.0% |
| 2021 Q2 | -3.2 Million USD | 1.96% |
| 2020 Q2 | -3.26 Million USD | -11.8% |
| 2020 Q4 | -3.54 Million USD | -12.6% |
| 2020 Q3 | -3.15 Million USD | 3.55% |
| 2020 FY | - USD | -20.41% |
| 2020 Q1 | -2.92 Million USD | -46.22% |
| 2019 Q2 | -3.08 Million USD | -18.72% |
| 2019 Q3 | -3 Million USD | 2.69% |
| 2019 FY | - USD | -3.9% |
| 2019 Q4 | -1.99 Million USD | 33.5% |
| 2019 Q1 | -2.6 Million USD | -69.95% |
| 2018 Q3 | -3.48 Million USD | -41.76% |
| 2018 Q1 | -2.33 Million USD | -450.07% |
| 2018 Q4 | -1.53 Million USD | 56.08% |
| 2018 FY | - USD | -44.82% |
| 2018 Q2 | -2.45 Million USD | -5.31% |
| 2017 Q2 | -2.48 Million USD | 26.12% |
| 2017 Q4 | 667 Thousand USD | 128.11% |
| 2017 Q1 | -3.36 Million USD | 11.27% |
| 2017 FY | - USD | 42.54% |
| 2017 Q3 | -2.37 Million USD | 4.43% |
| 2016 FY | - USD | 18.04% |
| 2016 Q1 | -3.28 Million USD | -55.24% |
| 2016 Q2 | -2.49 Million USD | 24.03% |
| 2016 Q3 | -2.85 Million USD | -14.21% |
| 2016 Q4 | -3.78 Million USD | -32.77% |
| 2015 Q3 | -3.69 Million USD | 19.04% |
| 2015 Q1 | -4.56 Million USD | -11.53% |
| 2015 Q4 | -2.11 Million USD | 42.62% |
| 2015 Q2 | -4.55 Million USD | 0.15% |
| 2015 FY | - USD | 12.7% |
| 2014 Q1 | -4.62 Million USD | -52.91% |
| 2014 Q4 | -4.09 Million USD | -5.16% |
| 2014 FY | - USD | -11.5% |
| 2014 Q2 | -4.67 Million USD | -1.1% |
| 2014 Q3 | -3.89 Million USD | 16.78% |
| 2013 Q1 | -4.19 Million USD | 40.76% |
| 2013 Q4 | -3.02 Million USD | 27.24% |
| 2013 FY | - USD | 14.13% |
| 2013 Q3 | -4.15 Million USD | -0.8% |
| 2013 Q2 | -4.12 Million USD | 1.72% |
| 2012 Q3 | -4.41 Million USD | -36.43% |
| 2012 Q2 | -3.23 Million USD | 2.62% |
| 2012 Q1 | -3.32 Million USD | 63.63% |
| 2012 Q4 | -7.08 Million USD | -60.5% |
| 2012 FY | - USD | 1.64% |
| 2011 Q3 | -3.17 Million USD | -11.58% |
| 2011 Q2 | -2.84 Million USD | 11.63% |
| 2011 Q1 | -3.21 Million USD | 27.34% |
| 2011 FY | - USD | -11.38% |
| 2011 Q4 | -9.13 Million USD | -188.2% |
| 2010 Q2 | -3.65 Million USD | 7.75% |
| 2010 Q3 | -3.57 Million USD | 2.22% |
| 2010 Q4 | -4.42 Million USD | -23.91% |
| 2010 Q1 | -3.95 Million USD | -13.28% |
| 2010 FY | - USD | -34.22% |
| 2009 Q4 | -3.49 Million USD | -50.71% |
| 2009 FY | - USD | -1.55% |
| 2009 Q1 | -2.64 Million USD | 7.62% |
| 2009 Q2 | -3.82 Million USD | -44.67% |
| 2009 Q3 | -2.31 Million USD | 39.37% |
| 2008 FY | - USD | 34.88% |
| 2008 Q4 | -2.86 Million USD | 13.9% |
| 2008 Q3 | -3.32 Million USD | -19.14% |
| 2008 Q1 | -3.11 Million USD | 13.65% |
| 2008 Q2 | -2.79 Million USD | 10.55% |
| 2007 Q2 | -4.05 Million USD | 14.52% |
| 2007 Q3 | -6.41 Million USD | -58.0% |
| 2007 Q1 | -4.74 Million USD | -28.41% |
| 2007 Q4 | -3.61 Million USD | 43.65% |
| 2007 FY | - USD | -4.84% |
| 2006 Q3 | -3.59 Million USD | 24.34% |
| 2006 FY | - USD | -238.89% |
| 2006 Q2 | -4.75 Million USD | 13.24% |
| 2006 Q4 | -3.69 Million USD | -2.7% |
| 2006 Q1 | -5.48 Million USD | -757.43% |
| 2005 Q1 | 202 Thousand USD | -98.34% |
| 2005 Q4 | 834 Thousand USD | 142.08% |
| 2005 FY | - USD | -135.71% |
| 2005 Q2 | -968 Thousand USD | -579.21% |
| 2005 Q3 | -1.98 Million USD | -104.75% |
| 2004 FY | - USD | 91.58% |
| 2004 Q1 | -1.03 Million USD | -56.24% |
| 2004 Q2 | 1.52 Million USD | 247.16% |
| 2004 Q3 | 1.95 Million USD | 27.67% |
| 2004 Q4 | 12.19 Million USD | 524.69% |
| 2003 FY | - USD | 210.95% |
| 2003 Q4 | -665 Thousand USD | -132.52% |
| 2003 Q3 | 2.04 Million USD | 421.68% |
| 2003 Q1 | -1.47 Million USD | 37.39% |
| 2003 Q2 | 392 Thousand USD | 126.54% |
| 2002 Q1 | -1.45 Million USD | 4.84% |
| 2002 Q4 | -1.11 Million USD | -28.63% |
| 2002 Q3 | -1.83 Million USD | -48.14% |
| 2002 Q2 | -1.91 Million USD | 14.91% |
| 2002 FY | - USD | 16.82% |
| 2001 Q2 | -2.27 Million USD | 7.27% |
| 2001 Q3 | -2.05 Million USD | 8.24% |
| 2001 Q4 | -1.52 Million USD | 25.74% |
| 2001 FY | - USD | 2.32% |
| 2001 Q1 | -2.42 Million USD | -3.38% |
| 2000 Q3 | -2.05 Million USD | 1.43% |
| 2000 FY | - USD | 8.87% |
| 2000 Q2 | -2.09 Million USD | -1.72% |
| 2000 Q1 | -2.03 Million USD | -6.91% |
| 2000 Q4 | -2.37 Million USD | -14.95% |
| 1999 FY | - USD | -38.81% |
| 1999 Q4 | -1.9 Million USD | 0.0% |
| 1999 Q3 | -1.93 Million USD | 32.14% |
| 1999 Q2 | -2.8 Million USD | 6.67% |
| 1999 Q1 | -2.86 Million USD | -150.0% |
| 1998 Q1 | -1.5 Million USD | 0.0% |
| 1998 Q2 | -1.8 Million USD | -12.5% |
| 1998 Q3 | -1.6 Million USD | 0.0% |
| 1998 FY | - USD | -3.08% |
| 1998 Q4 | -1.8 Million USD | 33.33% |
| 1997 Q2 | -1 Million USD | 60.0% |
| 1997 Q3 | -1.5 Million USD | -50.0% |
| 1997 FY | - USD | -30.0% |
| 1997 Q4 | -1.4 Million USD | -6.67% |
| 1997 Q1 | -2.5 Million USD | -78.57% |
| 1996 Q1 | -800 Thousand USD | 74.19% |
| 1996 Q4 | -1.4 Million USD | 6.67% |
| 1996 FY | - USD | -525.0% |
| 1996 Q3 | -1.5 Million USD | -50.0% |
| 1996 Q2 | -1 Million USD | -25.0% |
| 1995 Q4 | -3.1 Million USD | -542.86% |
| 1995 Q3 | 700 Thousand USD | 0.0% |
| 1995 Q1 | 700 Thousand USD | 0.0% |
| 1995 Q2 | 700 Thousand USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ampio Pharmaceuticals, Inc. | - USD | Infinity% |
| Armata Pharmaceuticals, Inc. | -39.91 Million USD | 20.642% |
| Actinium Pharmaceuticals, Inc. | -51.13 Million USD | 38.044% |
| Azitra, Inc. | -10.67 Million USD | -196.8% |
| Can-Fite BioPharma Ltd. | -8.18 Million USD | -287.262% |
| Chromocell Therapeutics Corporation | -6.86 Million USD | -361.625% |
| Calidi Biotherapeutics, Inc. | -28.6 Million USD | -10.762% |
| CEL-SCI Corporation | -27.56 Million USD | -14.94% |
| iBio, Inc. | -14.02 Million USD | -125.933% |
| Lineage Cell Therapeutics, Inc. | -24.73 Million USD | -28.08% |
| MAIA Biotechnology, Inc. | -20.18 Million USD | -56.959% |
| Matinas BioPharma Holdings, Inc. | -22.82 Million USD | -38.786% |
| Navidea Biopharmaceuticals, Inc. | -13.87 Million USD | -128.308% |
| NovaBay Pharmaceuticals, Inc. | -4.8 Million USD | -559.958% |
| NanoViricides, Inc. | -7.75 Million USD | -308.374% |
| Oragenics, Inc. | -20.87 Million USD | -51.733% |
| BiomX Inc. | -22.81 Million USD | -38.847% |
| BiomX Inc. | -22.81 Million USD | -38.847% |
| Protalix BioTherapeutics, Inc. | 11.65 Million USD | 371.891% |
| Palatin Technologies, Inc. | -29.03 Million USD | -9.117% |
| Scorpius Holdings, Inc. | -35.08 Million USD | 9.704% |